Wealthspire Advisors, L.P. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Wealthspire Advisors, L.P. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$82,000
+60.8%
656
+75.9%
0.01%
+20.0%
Q4 2018$51,000
-51.4%
373
-2.4%
0.01%
-44.4%
Q3 2018$105,000
+34.6%
382
+1.6%
0.01%
+28.6%
Q2 2018$78,000
+50.0%
376
+19.7%
0.01%
+40.0%
Q1 2018$52,000
+48.6%
314
+21.2%
0.01%
+66.7%
Q4 2017$35,000
+29.6%
259
+30.8%
0.00%0.0%
Q3 2017$27,000
+440.0%
198
+340.0%
0.00%
+200.0%
Q2 2017$5,000450.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
KNOTT DAVID M 1,249,766$58,726,504,00011.17%
BVF INC/IL 1,108,763$52,101,00010.82%
GROW Partners, LLC 132,500$6,226,0005.58%
CARDINAL CAPITAL MANAGEMENT LLC /CT 936,825$44,021,0002.73%
First Light Asset Management, LLC 76,366$3,588,0002.45%
Healthcare Value Capital, LLC 50,000$2,350,0002.27%
OBERWEIS ASSET MANAGEMENT INC/ 168,337$7,910,0002.17%
RK Capital 174,283$8,190,0001.67%
Nichols Asset Management LLC 133,368$6,267,0001.30%
ASHFORD CAPITAL MANAGEMENT INC 108,289$5,089,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders